Human antibodies to PCSK9 for use in methods of treating particular groups of subjects Grant US-11246925-B2 United States of America 15 Feb 2022
DOSING REGIMENS FOR USE WITH PCSK9 INHIBITORS Application EP-3882273-A1 European Patent Office 22 Sep 2021
Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein… Grant US-11116839-B2 United States of America 14 Sep 2021
Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody Grant US-10995150-B2 United States of America 04 May 2021